$ARWR -66% on bad news. Arrowhead to focus resou
Post# of 22706
![Avatar](/images/ProfileImages/555898396_1251_245071401_1251_small200.png)
Arrowhead to focus resources on subcutaneous and extra-hepatic RNAi therapeutics; three clinical-stage drug candidates axed; 30% of workforce cut; shares down 2% after hours
http://seekingalpha.com/news/3227473-arrowhea...ical-stage
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)